Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
- Published In:
- Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 41(5), 1171-1181 (2020)
- Authors:
- Muresanu, Dafin F, Florian, Stefan, Hömberg, Volker, Matula, Christian, von Steinbüchel, Nicole, Vos, Pieter E, von Wild, Klaus, Birle, Codruta, Muresanu, Ioana, Slavoaca, Dana, Rosu, Olivia Verisezan, Strilciuc, Stefan, Vester, Johannes
- Database ID:
- RPEP-05018
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05018APA
Muresanu, Dafin F; Florian, Stefan; Hömberg, Volker; Matula, Christian; von Steinbüchel, Nicole; Vos, Pieter E; von Wild, Klaus; Birle, Codruta; Muresanu, Ioana; Slavoaca, Dana; Rosu, Olivia Verisezan; Strilciuc, Stefan; Vester, Johannes. (2020). Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 41(5), 1171-1181. https://doi.org/10.1007/s10072-019-04181-y
MLA
Muresanu, Dafin F, et al. "Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020. https://doi.org/10.1007/s10072-019-04181-y
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and safety of cerebrolysin in neurorecovery after m..." RPEP-05018. Retrieved from https://rethinkpeptides.com/research/muresanu-2020-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.